Micki Prager

Randomized Phase II Trial of Anthracycline-free and Anthracycline-containing Neoadjuvant Carboplatin Chemotherapy Regimens in Stage I–III Triple-negative Breast Cancer (NeoSTOP)

A. Godwin, R. Salgado, B. Kimler, 2020, Clinical Cancer Research.

Romidepsin (HDACi) plus cisplatin and nivolumab triplet combination in patients with metastatic triple negative breast cancer (mTNBC).

A. Godwin, B. Kimler, I. Mayer, 2021 .